Prescription drug costs remain a top concern for plan sponsors, and the landscape keeps shifting. From rising GLP-1 utilization to biosimilar developments and IRA-driven pricing changes, staying current is essential for smart planning. Join Conrad Siegel’s Health & Welfare Team for a webinar on Tuesday, September 29th at 11:00 AM for a look at where prescription drug spend is heading. Using client examples and survey data, this session covers year-over-year Rx and GLP-1 trends, weight management coverage decisions, and the cost, rebate, and contract implications employers should watch.
By the end of this session, attendees will be able to:
- Identify key drivers of prescription drug trend, including client Rx/GLP-1 spend data and survey benchmarks on weight management coverage.
- Understand the evolving biosimilar landscape and its impact on cost management.
- Explain how IRA drug pricing provisions are affecting the market.
- Assess how market changes affect cost, contracts, and cash flow, and identify next steps ahead of 2027.